Journal
EUROPEAN RADIOLOGY
Volume 32, Issue 8, Pages 5119-5133Publisher
SPRINGER
DOI: 10.1007/s00330-022-08643-4
Keywords
Carcinoma; hepatocellular; Transcriptome; Histology; Radiology; Magnetic resonance imaging
Ask authors/readers for more resources
HCC is a diverse group of tumors in terms of histology, genetics, and protein expression. Advancements in imaging techniques have made imaging diagnosis a critical part of managing HCC in the clinical setting. There is increasing evidence of correlation between imaging phenotypes and histologic, molecular, and genetic characteristics of different HCC subtypes. Further research on radiological characteristics of HCC subtypes may enable non-invasive diagnosis and serve as biomarkers for prognosis, molecular characteristics, and therapeutic response.
HCC is a heterogeneous group of tumors in terms of histology, genetic aberration, and protein expression. Advancements in imaging techniques have allowed imaging diagnosis to become a critical part of managing HCC in the clinical setting, even without pathologic diagnosis. With the identification of many HCC subtypes, there is increasing correlative evidence between imaging phenotypes and histologic, molecular, and genetic characteristics of various HCC subtypes. In this review, current knowledge of histologic heterogeneity of HCC correlated to features on gadolinium-enhanced dynamic liver MRI will be discussed. In addition, HCC subtype classification according to transcriptomic profiles will be outlined with descriptions of histologic, genetic, and molecular characteristics of some relatively well-established morphologic subtypes, namely the low proliferation class (steatohepatitic HCC and CTNNB1-mutated HCC) and the high proliferation class (macrotrabecular-massive HCC (MTM-HCC), scirrhous HCC, and CK19-positive HCC). Characteristics of sarcomatoid HCC and fibrolamellar HCC will also be discussed. Further research on radiological characteristics of HCC subtypes may ultimately enable non-invasive diagnosis and serve as a biomarker in predicting prognosis, molecular characteristics, and therapeutic response. In the era of precision medicine, a multidisciplinary effort to develop an integrated radiologic and clinical diagnostic system of various HCC subtypes is necessary.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available